Merck (MRK GY) raises guidance; net sales of EUR 20.7-22.1bln for FY (exp. 21.29bln), EBITDA expected to grow c. EUR 5.8-6.4bln for FY (exp. 5.991bln)

Q2 results

 

26 Jul 2024 - 17:51- EquitiesImportant- Source: Newswires

Pharmaceuticals (Group)Pharmaceuticals, Biotechnology & Life SciencesPharmaceuticalsMerck KGaAMerck & Co IncMRK.GYEquitiesGermanyMRKDAX 40 IndexS&P 500 IndexEuropeEU SessionUS SessionImportantEU SessionUS SessionImportantEUR

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: